NCT07263919 Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal Squamous Cell Carcinoma (ESCC) Status RECRUITING Phase PHASE2
NCT07158840 AK112 in Non-squamous Non-small Cell Lung Cancer (NSCLC)Patients With Actionable Genomic Alterations (AGA) Who Have Failed to Previous Tyrosine Kinase Inhibitor (TKI) Treatment Status NOT_YET_RECRUITING Phase PHASE2
NCT07114315 A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer Status RECRUITING Phase PHASE2
NCT07052253 A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC. Status RECRUITING Phase PHASE2
NCT07043283 A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Healthy Male Chinese Subjects Status COMPLETED Phase PHASE1
NCT07023315 A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma Status RECRUITING Phase PHASE3
NCT07010263 A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy Status RECRUITING Phase PHASE3
NCT06984718 A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC Status NOT_YET_RECRUITING Phase PHASE2
NCT06953999 A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer Status RECRUITING Phase PHASE3
NCT06951646 ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive) Status RECRUITING Phase PHASE2
NCT06951503 AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer Status RECRUITING Phase PHASE3
NCT06943820 AK129 Combination Therapy for Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06938321 A Study of AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06929663 A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06928389 Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT06919510 A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer Status NOT_YET_RECRUITING Phase PHASE2